2 studies found for:    21383241 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Tofacitinib;   Drug: Placebo
2 Completed
Has Results
A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: CP-690,550;   Drug: Placebo

Indicates status has not been verified in more than two years